BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21860085)

  • 1. Regional comparison of the neurogenic effects of CNTF-derived peptides and cerebrolysin in AβPP transgenic mice.
    Rockenstein E; Ubhi K; Doppler E; Novak P; Moessler H; Li B; Blanchard J; Grundke-Iqbal I; Iqbal K; Mante M; Adame A; Crews L; Masliah E
    J Alzheimers Dis; 2011; 27(4):743-52. PubMed ID: 21860085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Cerebrolysin on neurogenesis in an APP transgenic model of Alzheimer's disease.
    Rockenstein E; Mante M; Adame A; Crews L; Moessler H; Masliah E
    Acta Neuropathol; 2007 Mar; 113(3):265-75. PubMed ID: 17131129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrolysin modulates pronerve growth factor/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer's disease.
    Ubhi K; Rockenstein E; Vazquez-Roque R; Mante M; Inglis C; Patrick C; Adame A; Fahnestock M; Doppler E; Novak P; Moessler H; Masliah E
    J Neurosci Res; 2013 Feb; 91(2):167-77. PubMed ID: 23152192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuro-peptide treatment with Cerebrolysin improves the survival of neural stem cell grafts in an APP transgenic model of Alzheimer disease.
    Rockenstein E; Desplats P; Ubhi K; Mante M; Florio J; Adame A; Winter S; Brandstaetter H; Meier D; Masliah E
    Stem Cell Res; 2015 Jul; 15(1):54-67. PubMed ID: 26209890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early in vivo Effects of the Human Mutant Amyloid-β Protein Precursor (hAβPPSwInd) on the Mouse Olfactory Bulb.
    Rusznák Z; Kim WS; Hsiao JH; Halliday GM; Paxinos G; Fu Y
    J Alzheimers Dis; 2016; 49(2):443-57. PubMed ID: 26484907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciliary neurotrophic factor cell-based delivery prevents synaptic impairment and improves memory in mouse models of Alzheimer's disease.
    Garcia P; Youssef I; Utvik JK; Florent-Béchard S; Barthélémy V; Malaplate-Armand C; Kriem B; Stenger C; Koziel V; Olivier JL; Escanye MC; Hanse M; Allouche A; Desbène C; Yen FT; Bjerkvig R; Oster T; Niclou SP; Pillot T
    J Neurosci; 2010 Jun; 30(22):7516-27. PubMed ID: 20519526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of neurogenesis in two neurogenic regions of APPswe/PS1dE9 transgenic mice.
    Niidome T; Taniuchi N; Akaike A; Kihara T; Sugimoto H
    Neuroreport; 2008 Sep; 19(14):1361-4. PubMed ID: 18766011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
    Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
    Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
    J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuron and neuroblast numbers and cytogenesis in the dentate gyrus of aged APP
    Olesen LØ; Sivasaravanaparan M; Severino M; Babcock AA; Bouzinova EV; West MJ; Wiborg O; Finsen B
    Neurobiol Dis; 2017 Aug; 104():50-60. PubMed ID: 28461249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell proliferation and neurogenesis alterations in Alzheimer's disease and diabetes mellitus mixed murine models.
    Hierro-Bujalance C; Del Marco A; José Ramos-Rodríguez J; Infante-Garcia C; Bella Gomez-Santos S; Herrera M; Garcia-Alloza M
    J Neurochem; 2020 Sep; 154(6):673-692. PubMed ID: 32068886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurogenic responses to amyloid-beta plaques in the brain of Alzheimer's disease-like transgenic (pPDGF-APPSw,Ind) mice.
    Gan L; Qiao S; Lan X; Chi L; Luo C; Lien L; Yan Liu Q; Liu R
    Neurobiol Dis; 2008 Jan; 29(1):71-80. PubMed ID: 17916429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing AβPP containing the wild-type β-secretase site sequence.
    Kindy MS; Yu J; Zhu H; El-Amouri SS; Hook V; Hook GR
    J Alzheimers Dis; 2012; 29(4):827-40. PubMed ID: 22337825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of the cerebrovascular amyloidosis in a transgenic model of Alzheimer's disease with the neurotrophic compound cerebrolysin.
    Rockenstein E; Adame A; Mante M; Larrea G; Crews L; Windisch M; Moessler H; Masliah E
    J Neural Transm (Vienna); 2005 Feb; 112(2):269-82. PubMed ID: 15657642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrahydrohyperforin increases adult hippocampal neurogenesis in wild-type and APPswe/PS1ΔE9 mice.
    Abbott AC; Calderon Toledo C; Aranguiz FC; Inestrosa NC; Varela-Nallar L
    J Alzheimers Dis; 2013; 34(4):873-85. PubMed ID: 23302657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interruption of beta-catenin signaling reduces neurogenesis in Alzheimer's disease.
    He P; Shen Y
    J Neurosci; 2009 May; 29(20):6545-57. PubMed ID: 19458225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuroprotective effects of Cerebrolysin in a transgenic model of Alzheimer's disease are associated with improved behavioral performance.
    Rockenstein E; Adame A; Mante M; Moessler H; Windisch M; Masliah E
    J Neural Transm (Vienna); 2003 Nov; 110(11):1313-27. PubMed ID: 14628195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirtuin 2 Inhibition Improves Cognitive Performance and Acts on Amyloid-β Protein Precursor Processing in Two Alzheimer's Disease Mouse Models.
    Biella G; Fusco F; Nardo E; Bernocchi O; Colombo A; Lichtenthaler SF; Forloni G; Albani D
    J Alzheimers Dis; 2016 Jun; 53(3):1193-207. PubMed ID: 27372638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice.
    Plaschke K; Kopitz J; Siegelin M; Schliebs R; Salkovic-Petrisic M; Riederer P; Hoyer S
    J Alzheimers Dis; 2010; 19(2):691-704. PubMed ID: 20110613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental enrichment reverses Aβ pathology during pregnancy in a mouse model of Alzheimer's disease.
    Ziegler-Waldkirch S; Marksteiner K; Stoll J; d'Errico P; Friesen M; Eiler D; Neudel L; Sturn V; Opper I; Datta M; Prinz M; Meyer-Luehmann M
    Acta Neuropathol Commun; 2018 May; 6(1):44. PubMed ID: 29855361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.